She has pioneered work in bioengineering bacterial protein compartments and Virus-Like Particles (VLPs), leading to the development of novel tools and applications. Dr Frank’s research focuses on creating new modular protein-based vaccine technologies, combining strategies for antigen display and cargo encapsulation using protein nanoparticles to create a versatile platform for vaccine applications. In addition to her research, Dr Frank contributes to vaccine manufacturing training as the module leader for the UCL-MIT MBI Vaccine Bioprocess Development and Commercialisation course.

She supports knowledge dissemination in her roles as Co-Chair at the ECI Microbial Engineering and ECI Vaccine Technology conference series and as an active member of the Royal Society of Chemistry’s (RSC) Analytical Biosciences committee.